Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. [electronic resource]
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Jul 2009
- 392-3 p. digital
Publication Type: Letter
1473-5733
10.1097/MBC.0b013e32832aec47 doi
Aged Aged, 80 and over Anticoagulants--adverse effects Atrial Fibrillation--drug therapy Female Frail Elderly Hemorrhage--chemically induced Humans Male Risk Thrombophilia--drug therapy Vitamin K--antagonists & inhibitors Warfarin--adverse effects